Abstract—The presence of a significant and constantly growing global prevalence of autism spectrum disorders (ASD) coupled with the ongoing search for optimal drugs and treatments has aroused heightened interest in this disease. The modern medical literature contains many publications on the impairments in the functioning and interaction of neurotransmitter systems in ASD and methods for their pharmacological correction. It has been established that the serotonergic, glutamatergic, GABAergic, dopaminergic, cholinergic, and opiate systems of the brain may be involved in the pathogenesis of ASD along with disturbances in the metabolism of oxytocin, arginine-vasopressin, and melatonin. This review presents an analysis of the main changes in these systems in ASD, mechanisms of drug-induced effects, and directions for the ongoing search for relevant pathogenic targets and drugs.
Similar content being viewed by others
REFERENCES
Hyman, S.L., Levy, S.E., and Myers, S.M., Pediatrics, 2020, vol. 145, no. 1, e20193447.
Maenner, M.J., Shaw, K.A., Baio, J., Washington, A., Patrick, M., DiRienzo, M., Christensen, D.L., Wiggins, L.D., Pettygrove, S., Andrews, J.G., et al., MMWR Surveill. Summ., 2020, vol. 69, no. 4, pp. 1–12.
Rasstroistva autisticheskogo spektra v detskom vozraste: diagnostika, terapiya, profilaktika, reabilitatsiya. Klinicheskie rekomendatsii (Disorders of Autistic Spectrum in Children: Diagnostics, Therapy, Prophylactics, and Rehabilitation. Clinical Recommendations), Moscow: Obshchestvennaya organizatsiya “Rossiiskoe obshchestvo psikhiatrov”. 2020.
Young, S., Hollingdale, J., Absoud, M., Bolton, P., Branney, P., Colley, W., Craze, E., Dave, M., Deeley, Q., Farrag, E., et al., BMC Med., 2020, vol. 18, no. 1, p. 146.
Marotta, R., Risoleo, M.C., Messina, G., Parisi, L., Carotenuto, M., Vetri, L., and Roccella, M., Brain Sci., 2020, vol. 10, no. 3, p. 163.
Guang, S., Pang, N., Deng, X., Yang, L., He, F., Wu, L., Chen, C., Yin, F., and Peng, J., Front. Cell. Neurosci., 2018, vol. 12, no. 470.
Arya, A. and Sindhwani, G., Int. J. Pharm. Sci. Res., 2016, vol. 7, no. 9, pp. 3567–3575.
Williamson, E., Sathe, N.A., Andrews, J.C., Krishnaswami, S., McPheeters, M.L., Fonnesbeck, C., Sanders, K., Weitlauf, A., and Warren, Z., Medical Therapies for Children With Autism Spectrum Disorder—An Update. Rockville (MD): Agency for Healthcare Research and Quality (US), 2017.
Jenkins, T.A., Nguyen, J.C., Polglaze, K.E., and Bertrand, P.P., Nutrients, 2016, vol. 8, no. 1, p. 56.
Chen, R., Davis, L.K., Guter, S., Wei, Q., Jacob, S., Potter, M.H., Cox, N.J., Cook, E.H., Sutcliffe, J.S., and Li, B., Mol. Autism, 2017, vol. 8, p. 14.
Ellenbroek, B.A., August, C., and Youn, J., Front. Neurosci., 2016, vol. 10, p. 424.
Aaron, E., Montgomery, A., Ren, X., Guter, S., Anderson, G., Carneiro, A., Jacob, S., Mosconi, M., Pandey, G.N., Cook, E., et al., J. Autism Dev. Disord., 2019, vol. 49, no. 6, pp. 2417–2425.
Nakai, N., Nagano, M., Saitow, F., Watanabe, Y., Kawamura, Y., Kawamoto, A., Tamada, K., Mizuma, H., Onoe, H., Watanabe, Y., et al., Sci. Adv., 2017, vol. 3, no. 6, e1603001.
Chugani, D.C., Muzik, O., Behen, M., Rothermel, R., Janisse, J.J., Lee, J., and Chugani, H.T., Ann. Neurol., 1999, vol. 45, no. 3, pp. 287–295.
Hwang, B.J., Mohamed, M.A., and Brasic, J.R., Int. Rev. Psychiatry, 2017, vol. 29, no. 6, pp. 530–554.
Abdulamir, H.A., Abdul-Rasheed, O.F., and Abdulghani, E.A., Saudi. Med. J., 2018, vol. 39, no. 5, pp. 487–494.
Veenstra-VanderWeele, J., Muller, C.L., Iwamoto, H., Sauer, J.E., Owens, W.A., Shah, C.R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B.J., et al., Proc. Natl. Acad. Sci. USA, 2012, vol. 109, no. 14, pp. 5469–5474.
Zhou, M.S., Nasir, M., Farhat, L.C., Kook, M., Artukoglu, B.B., and Bloch, M.H., J. Am. Acad. Child. Adolesc. Psychiatry, 2020, vol. 60, no. 1, pp. 35–45.
Hollander, E., Soorya, L., Chaplin, W., Anagnostou, E., Taylor, B.P., Ferretti, C.J., Wasserman, S., Swanson, E., and Settipani, C., Am. J. Psychiatry, 2012, vol. 169, no. 3, pp. 292–299.
Yu, Y., Chaulagain, A., Pedersen, S.A., Lydersen, S., Leventhal, B.L., Szatmari, P., Aleksic, B., Ozaki, N., and Skokauskas, N., BMC Psychiatry, 2020, vol. 20, no. 1, p. 121.
Remington, G., Sloman, L., Konstantareas, M., Parker, K., and Gow, R., J. Clin. Psychopharmacol., 2001, vol. 21, no. 4, pp. 440–444.
Chugani, D.C., Chugani, H.T., Wiznitzer, M., Parikh, S., Evans, P.A., Hansen, R.L., Nass, R., Janisse, J.J., Dixon-Thomas, P., Behen, M., et al., J. Pediatr., 2016, vol. 170, pp. 45–53.
Dichter, G.S., Damiano, C.A., and Allen, J.A., J. Neurodev. Disord., 2012, vol. 4, no. 1, p. 19.
Ernst, M., Zametkin, A.J., Matochik, J.A., Pascualvaca, D., and Cohen, R.M., Lancet, 1997, vol. 350, no. 9078, p. 638.
Chevallier, C., Kohls, G., Troiani, V., Brodkin, E.S., and Schultz, R.T., Trends Cogn. Sci., 2012, vol. 16, no. 4, pp. 231–239.
Hellings, J.A., Arnold, L.E., and Han, J.C., Expert Opin. Pharmacother., 2017, vol. 18, no. 6, pp. 581–588.
Seeman, P., Clin. Schizophr. Relat. Psychoses, 2010, vol. 4, no. 1, pp. 56–73.
Pavăl, D., Dev. Neurosci., 2017, vol. 39, no. 5, pp. 355–360.
Kim, H., Lim, C.S., and Kaang, B.K., Behav. Brain. Funct., 2016, vol. 12, no. 1, p. 3.
Lee, Y., Kim, H., Kim, J.E., Park, J.Y., Choi, J., Lee, J.E., Lee, E.H., and Han, P.L., Mol. Neurobiol., 2018, vol. 55, no. 7, pp. 5658–5671.
Minzer, K., Lee, O., Hong, J.J., and Singer, H.S., J. Neurol. Sci., 2004, vol. 219, nos 1-2, pp. 55–61.
Herborg, F., Andreassen, T.F., Berlin, F., Loland, C.J., and Gether, U., J. Biol. Chem., 2018, vol. 293, no. 19, pp. 7250–7262.
Gangi, D.N., Messinger, D.S., Martin, E.R., and Cuccaro, M.L., Autism Res, 2016, vol. 9, no. 11, pp. 1142–1150.
Staal, W.G., Langen, M., van Dijk, S., Mensen, V.T., and Durston, S., Br. J. Psychiatry, 2015, vol. 206, no. 5, pp. 431–432.
Nguyen, M., Roth, A., Kyzar, E.J., Poudel, M.K., Wong, K., Stewart, A.M., and Kalueff, A.V., Neurochem. Int., 2014, vol. 66, pp. 15–26.
DiCarlo, G.E., Aguilar, J.I., Matthies, H.J., Harrison, F.E., Bundschuh, K.E., West, A., Hashemi, P., Herborg, F., Rickhag, M., Chen, H., et al., J. Clin. Invest., 2019, vol. 129, no. 8, pp. 3407–3419.
Gadow, K.D., Pinsonneault, J.K., Perlman, G., and Sadee, W., Res. Dev. Disabil., 2014, vol. 35, no. 7, pp. 1658–1665.
Yoshida, K., Bies, R.R., Suzuki, T., Remington, G., Pollock, B.G., Mizuno, Y., Mimura, M., and Uchida, H., Schizophr. Res., 2014, vol. 153, nos. 1–3, pp. 184–188.
Li, P., Snyder, G.L., and Vanover, K.E., Curr. Top. Med. Chem., 2016, vol. 16, no. 29, pp. 3385–3403.
Mannens, G., Huang, M.L., Meuldermans, W., Hendrickx, J., Woestenborghs, R., and Heykants, J., Drug Metab. Dispos., 1993, vol. 21, no. 6, pp. 1134–1141.
Kusumi, I., Boku, S., and Takahashi, Y., Psychiatry Clin. Neurosci., 2015, vol. 69, no. 5, pp. 243–258.
Poo, S.X. and Agius, M., Psychiatr. Danub., 2015, vol. 27, no. 1, pp. 255–260.
Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., and Dunbar, F., Pediatrics, 2004, vol. 114, no. 5, pp. e634–e641.
Hirsch, L.E. and Pringsheim, T., Cochrane Database Syst. Rev., 2016, vol. 6, p. CD009043.
Maneeton, N., Maneeton, B., Putthisri, S., Woottiluk, P., Narkpongphun, A., and Srisurapanont, M., Neuropsychiatr. Dis. Treat., 2018, vol. 14, pp. 1811–1820.
Ichikawa, H., Mikami, K., Okada, T., Yamashita, Y., Ishizaki, Y., Tomoda, A., Ono, H., Usuki, C., and Tadori, Y., Child Psychiatry Hum. Dev., 2017, vol. 48, no. 5, pp. 796–806.
Ichikawa, H., Hiratani, M., Yasuhara, A., Tsujii, N., Oshimo, T., Ono, H., and Tadori, Y., Psychiatry Clin. Neurosci., 2018, vol. 72, no. 2, pp. 84–94.
Lee, E.S., Vidal, C., and Findling, R.L., J. Child Adolesc. Psychopharmacol., 2018, vol. 28, no. 9, pp. 582–605.
Loebel, A., Brams, M., Goldman, R.S., Silva, R., Hernandez, D., Deng, L., Mankoski, R., and Findling, R.L., J. Autism Dev. Disord., 2016, vol. 46, no. 4, pp. 1153–1163.
Dominick, K., Wink, L.K., McDougle, C.J., and Erickson, C.A., J. Child Adolesc. Psychopharmacol., 2015, vol. 25, no. 5, pp. 397–401.
Elbe, D. and Lalani, Z., J. Can. Acad. Child Adolesc. Psychiatry, 2012, vol. 21, no. 2, pp. 130–146.
Campbell, M., Armenteros, J.L., Malone, R.P., Adams, P.B., Eisenberg, Z.W., and Overall, J.E., J. Am. Acad. Child Adolesc. Psychiatry, 1997, vol. 36, no. 6, pp. 835–843.
Olloquequi, J., Cornejo-Cordova, E., Verdaguer, E., Soriano, F.X., Binvignat, O., Auladell, C., and Camins, A., J. Psychopharmacol., 2018, vol. 32, no. 3, pp. 265–275.
Carlsson, M.L., J. Neural. Transm. (Vienna), 1998, vol. 105, nos. 4–5, pp. 525–535.
Boksha, I.S., Autizm i Narusheniya Razvitiya, 2005, vol. 3, no. 2, pp. 1–24.
Rose, S., Niyazov, D.M., Rossignol, D.A., Goldenthal, M., Kahler, S.G., and Frye, R.E., Mol. Diagn. Ther., 2018, vol. 22, no. 5, pp. 571–593.
Hashem, S., Nisar, S., Bhat, A.A., Yadav, S.K., Azeem, M.W., Bagga, P., Fakhro, K., Reddy, R., Frenneaux, M.P., and Haris, M., Transl. Psychiatry, 2020, vol. 10, no. 1, p. 229.
Westmark, C.J., Mol. Neurobiol., 2019, vol. 56, no. 6, pp. 3904–3921.
Chung, C., Ha, S., Kang, H., Lee, J., Um, S.M., Yan, H., Yoo, Y.E., Yoo, T., Jung, H., Lee, D., et al., Biol. Psychiatry, 2019, vol. 85, no. 7, pp. 534–543.
Kang, J. and Kim, E., Front. Mol. Neurosci, 2015, vol. 8, p. 17.
Rinaldi, T., Kulangara, K., Antoniello, K., and Markram, H., Proc. Natl. Acad. Sci. USA, 2007, vol. 104, no. 33, pp. 13501–13506.
Naveed, S., Amray, A., Waqas, A., Chaudhary, A.M., and Azeem, M.W., Cureus, 2017, vol. 9, no. 11, p. e1888.
Minshawi, N.F., Wink, L.K., Shaffer, R., Plawecki, M.H., Posey, D.J., Liu, H., Hurwitz, S., McDougle, C.J., Swiezy, N.B., and Erickson, C.A., Mol. Autism, 2016, vol. 7, p. 2.
Aman, M.G., Findling, R.L., Hardan, A.Y., Hendren, R.L., Melmed, R.D., Kehinde-Nelson, O., Hsu, H.A., Trugman, J.M., Palmer, R.H., Graham, S.M., et al., J. Child Adolesc. Psychopharmacol., 2017, vol. 27, no. 5, pp. 403–412.
King, B.H., Wright, D.M., Handen, B.L., Sikich, L., Zimmerman, A.W., McMahon, W., Cantwell, E., Davanzo, P.A., Dourish, C.T., Dykens, E.M., et al., J. Am. Acad. Child Adolesc. Psychiatry, 2001, vol. 40, no. 6, pp. 658–665.
Goel, R., Hong, J.S., Findling, R.L., and Ji, N.Y., Int. Rev. Psychiatry, 2018, vol. 30, no. 1, pp. 78–95.
Hampson, D.R. and Blatt, G.J., Front. Neurosci., 2015, vol. 9, p. 420.
Naaijen, J., Bralten, J., Poelmans, G., Glennon, J.C., Franke, B., and Buitelaar, J.K., Transl. Psychiatry, 2017, vol. 7, no. 1.
Shetty, A.K. and Bates, A., Brain Res., 2016, vol. 1638, Pt. A, pp. 74–87.
García-Oscos, F., Torres-Ramírez, O., Dinh, L., Galindo-Charles, L., Pérez Padilla, E.A., Pineda, J.C., Atzori, M., and Salgado, H., Synapse, 2015, vol. 69, no. 3, pp. 115–127.
Di, J., Li, J., O’Hara, B., Alberts, I., Xiong, L., Li, J., and Li, X., Int. J. Dev. Neurosci., 2020, vol. 80, no. 2, pp. 73–85.
Al-Otaish, H., Al-Ayadhi, L., Bjørklund, G., Chirumbolo, S., Urbina, M.A., and El-Ansary, A., Metab. Brain Dis., vol. 33, no. 3, pp. 843–854.
Ford, T.C., Nibbs, R., and Crewther, D.P., PLoS One, 2017, vol. 12, no. 7.
Horder, J., Petrinovic, M.M., Mendez, M.A., Bruns, A., Takumi, T., Spooren, W., Barker, G.J., Kunnecke, B., and Murphy, D.G., Transl. Psychiatry, 2018, vol. 8, no. 1, p. 106.
Puts, N., Wodka, E.L., Harris, A.D., Crocetti, D., Tommerdahl, M., Mostofsky, S.H., and Edden, R., Autism Res., 2017, vol. 10, no. 4, pp. 608–619.
Mahdavi, M., Kheirollahi, M., Riahi, R., Khorvash, F., Khorrami, M., and Mirsafaie, M., J. Mol. Neurosci., 2018, vol. 65, no. 1, pp. 1–9.
Varman, D.R., Soria-Ortíz, M.B., Martínez-Torres, A., and Reyes-Haro, D., Neurosci. Let., 2018, vol. 687, pp. 158–163.
Hou, Q., Wang, Y., Li, Y., Chen, D., Yang, F., and Wang, S., Front. Behav. Neurosci., 2018, vol. 12, p. 182.
Veenstra-VanderWeele, J., Cook, E.H., King, B.H., Zarevics, P., Cherubini, M., Walton-Bowen, K., Bear, M.F., Wang, P.P., and Carpenter, R.L., Neuropsychopharmacology, 2017, vol. 42, no. 7, pp. 1390–1398.
Berry-Kravis, E., Hagerman, R., Visootsak, J., Budimirovic, D., Kaufmann, W.E., Cherubini, M., Zarevics, P., Walton-Bowen, K., Wang, P., Bear, M.F., et al., J. Neurodev. Disord., 2017, vol. 9, p. 3.
Lemonnier, E., Villeneuve, N., Sonie, S., Serret, S., Rosier, A., Roue, M., Brosset, P., Viellard, M., Bernoux, D., Rondeau, S., et al., Transl. Psychiatry, 2017, vol. 7, no. 5.
Schmitz, T.W. and Duncan, J., Trends Cogn. Sci, 2018, vol. 22, no. 5, pp. 422–437.
Hampel, H., Mesulam, M.M., Cuello, A.C., Farlow, M.R., Giacobini, E., Grossberg, G.T., Khachaturian, A.S., Vergallo, A., Cavedo, E., Snyder, P.J., et al., Brain, 2018, vol. 141, no. 7, pp. 1917–1933.
Avale, M.E., Chabout, J., Pons, S., Serreau, P., De Chaumont, F., Olivo-Marin, J.C., Bourgeois, J.P., Maskos, U., Changeux, J.P., and Granon, S., FASEB J., 2011, vol. 25, no. 7, pp. 2145–2155.
Varghese, M., Keshav, N., Jacot-Descombes, S., Warda, T., Wicinski, B., Dickstein, D.L., Harony-Nicolas, H., De Rubeis, S., Drapeau, E., Buxbaum, J.D., et al., Acta Neuropathol., 2017, vol. 134, no. 4, pp. 537–566.
Friedman, S.D., Shaw, D.W., Artru, A.A., Dawson, G., Petropoulos, H., and Dager, S.R., Arch. Gen. Psychiatry, 2006, vol. 63, no. 7, pp. 786–794.
Wang, L., Almeida, L.E., Spornick, N.A., Kenyon, N., Kamimura, S., Khaibullina, A., Nouraie, M., and Quezado, Z.M., Psychopharmacology (Berlin), 2015, vol. 232, no. 23, pp. 4303–4316.
Martin-Ruiz, C.M., Lee, M., Perry, R.H., Baumann, M., Court, J.A., and Perry, E.K., Brain Res. Mol. Brain Res., 2004, vol. 123, nos. 1–2, pp. 81–90.
Lee, M., Martin-Ruiz, C., Graham, A., Court, J., Jaros, E., Perry, R., Iversen, P., Bauman, M., and Perry, E., Brain, 2002, vol. 125, Pt. 7, pp. 1483–1495.
Léna, C., Popa, D., Grailhe, R., Escourrou, P., Changeux, J.P., and Adrien, J., J. Neurosci., 2004, vol. 24, no. 25, pp. 5711–5718.
Ross, S.A., Wong, J.Y., Clifford, J.J., Kinsella, A., Massalas, J.S., Horne, M.K., Scheffer, I.E., Kola, I., Waddington, J.L., Berkovic, S.F., and Drago, J., J. Neurosci., 2000, vol. 20, no. 17, pp. 6431–6441.
Wu, W.L., Adams, C.E., Stevens, K.E., Chow, K.H., Freedman, R., and Patterson, P.H., Brain Behav. Immun., 2015, vol. 46, pp. 192–202.
Gabis, L.V., Ben-Hur, R., Shefer, S., Jokel, A., and Shalom, D.B., J. Mol. Neurosci, 2019, vol. 69, no. 2, pp. 224–234.
Bruno, J.L., Hosseini, S.H., Lightbody, A.A., Manchanda, M.K., and Reiss, A.L., J. Psychopharmacol., 2019, vol. 33, no. 8, pp. 975–985.
Ghaleiha, A., Ghyasvand, M., Mohammadi, M.R., Farokhnia, M., Yadegari, N., Tabrizi, M., Hajiaghaee, R., Yekehtaz, H., and Akhondzadeh, S., J. Psychopharmacol., 2014, vol. 28, no. 7, pp. 677–685.
Souders, M.C., Zavodny, S., Eriksen, W., Sinko, R., Connell, J., Kerns, C., Schaaf, R., and Pinto-Martin, J., Curr. Psychiatry Rep., vol. 19, no. 6, p. 34.
Chuffa, L.G.A., Lupi, L.A., Cucielo, M.S., Silveira, H.S., Reiter, R.J., and Seiva, F.R.F., Int. J. Mol. Sci., 2019, vol. 21, no. 1, p. 300.
Jin, Y., Choi, J., Won, J., and Hong, Y., Molecules, 2018, vol. 23, no. 1, p. 198.
Tordjman, S., Najjar, I., Bellissant, E., Anderson, G.M., Barburoth, M., Cohen, D., Jaafari, N., Schischmanoff, O., Fagard, R., Lagdas, E., et al., Int. J. Mol. Sci., 2013, vol. 14, no. 10, pp. 20508–20542.
Braam, W., Ehrhart, F., Maas, A.P.H.M., Smits, M.G., and Curfs, L., Res. Dev. Disabil., 2018, vol. 82, pp. 79–89.
Rossignol, D.A. and Frye, R.E., Dev. Med. Child Neurol., 2011, vol. 53, no. 9, pp. 783–792.
Jenabi, E., Ataei, S., and Bashirian, S., Korean J. Pediatr., 2019, vol. 62, no. 11, pp. 405–409.
Gringras, P., Nir, T., Breddy, J., Frydman-Marom, A., and Findling, R.L., J. Am. Acad. Child Adolesc. Psychiatry, 2017, vol. 56, no. 11, pp. 948–957.
Howes, O.D., Rogdaki, M., Findon, J.L., Wichers, R.H., Charman, T., King, B.H., Loth, E., McAlonan, G.M., McCracken, J.T., Parr, J.R., et al., J. Psychopharmacol., 2018, vol. 32, no. 1, pp. 3–29.
Gagnon, K. and Godbout, R., Curr. Dev. Disord. Re, vol. 5, no. 3, pp. 197–206.
Husarova, V.M., Lakatosova, S., Pivovarciova, A., Babinska, K., Bakos, J., Durdiakova, J., Kubranska, A., Ondrejka, I., and Ostatnikova, D., Psychiatry Investig., 2016, vol. 13, no. 2, pp. 174–183.
Parker, K.J., Garner, J.P., Libove, R.A., Hyde, S.A., Hornbeak, K.B., Carson, D.S., Liao, C.P., Phillips, J.M., Hallmayer, J.F., and Hardan, A.Y., Proc. Natl. Acad. Sci. USA, 2014, vol. 111, no. 33, pp. 12258–12263.
Rajamani, K.T., Wagner, S., Grinevich, V., and Harony-Nicolas, H., Front. Synaptic Neurosci., 2018, vol. 10, p. 17.
Gauthier, C., Doyen, C., Amado, I., Loo, H., and Gaillard, R., Encephale, 2016, vol. 42, no. 1, pp. 24–31.
Ooi, Y.P., Weng, S.J., Kossowsky, J., Gerger, H., and Sung, M., Pharmacopsychiatry, 2017, vol. 50, no. 1, pp. 5–13.
Parker, K.J., Oztan, O., Libove, R.A., Sumiyoshi, R.D., Jackson, L.P., Karhson, D.S., Summers, J.E., Hinman, K.E., Motonaga, K.S., Phillips, J.M., et al., Proc. Natl. Acad. Sci. USA, 2017, vol. 114, no. 30, pp. 8119–8124.
Sandman, C.A. and Kemp, A.S., Pharmaceuticals (Basel), 2011. vol. 4, no. 2, pp. 366–381.
Roy, A., Roy, M., Deb, S., Unwin, G., and Roy, A., J. Intellect. Disabil. Res., 2015, vol. 59, no. 4, pp. 293–306.
Penke, B., Fulop, L., Szucs, M., and Frecska, E., Curr. Neuropharmacol., 2018, vol. 16, no. 1, pp. 97–116.
Delprat, B., Crouzier, L., Su, T.P., and Maurice, T., Adv. Exp. Med. Biol., 2020, vol. 1131, pp. 699–718.
Vavers, E., Zvejniece, L., Maurice, T., and Dambrova, M., Front. Pharmacol., 2019, vol. 10, p. 223.
Morales-Lázaro, S.L., González-Ramírez, R., and Rosenbaum, T., Front. Pharmacol., 2019, vol. 10, p. 419.
Su, T.P., Su, T.C., Nakamura, Y., and Tsai, S.Y., Trends Pharmacol. Sci., 2016, vol. 37, no. 4, pp. 262–278.
Nguyen, R.L., Medvedeva, Y.V., Ayyagari, T.E., Schmunk, G., and Gargus, J.J., Biochim. Biophys. Acta Mol. Cell. Res, 2018, vol. 1865, no. 11, Pt. B, pp. 1718–1732.
Seredenin, S.B. and Voronin, M.V., Eksperim. i Klin. Farmakologiya, 2009, vol. 72, no. 1, pp. 3–11.
Kadnikov, I.A., Voronin, M.V., and Seredenin, S.B., Farmakokinetika i Farmakodinamika, 2018, vol. 3, pp. 27–30.
Silkina, I.V., Gan’shina, T.S., Seredenin, S.B., and Mirzoyan, R.S., Eksperim. i Klin. Farmakologiya, 2005, vol. 68, no. 1, pp. 20–24.
Seredenin, S.B., Garibova, T.A., Kuznetsova, A.L., Voronin, M.V., Yarkova, M.A., and Voronina, T.A., Eksperim. i Klin. Farmakologiya, 2009, vol. 72, no. 1, pp. 15–28.
Yastrebov, D.V., Mikhailova, O.I., and Kostycheva, E.A., Psikhiatriya i Psikhofarmakoterapiya, 2013, vol. 15, no. 5, pp. 32–35.
Bogdan, N.G., Kolotilinskaya, N.V., Nadorov, S.A., Yarkova, M.A., and Badyshtov, B.A., Eksperim. i Klin. Farmakologiya, 2011, vol. 74, no. 8, pp. 8–12.
Syunyakov, T.S. and Neznamov, G.G., Ter. Arkh., 2016, vol. 88, no. 8, pp. 73–86.
Bekker, R.A. and Bykov, Yu.V., Psikhiatriya i PsikhoFarmakoterapiya, 2017, vol. 19, no. 4, pp. 12–21.
Kapitsa, I.G., Kalinina, A.P., Alymov, A.A., Voronina, T.A., and Seredenin, S.B., Byulleten’ Eksperimental’noi Biologii i Meditsiny, 2019, vol. 168, no. 8, pp. 191–194.
Kapitsa, I.G., Ivanova, E.A., Voronina, T.A., Kalinina, A.P., and Seredenin, S.B., Eksperim. i Klin. Farmakologiya, 2019, vol. 82, no. 10, pp. 3–7.
Seredinin, S.B., Kapitsa, I.G., Ivanova E.A., Voronina, T.A., RF Patent 2666598 C1, 2018.
Funding
No external financing was involved.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Alymov, A.A., Kapitsa, I.G. & Voronina, T.A. Neurochemical Mechanisms of Pathogenesis and Pharmacological Correction of Autism Spectrum Disorders: Current Concepts and Prospects. Neurochem. J. 15, 129–138 (2021). https://doi.org/10.1134/S1819712421020033
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712421020033